EcoDrugPlus

Alpha-Synuclein-Like

Ensembl ID : ENSPFOG00000010167
Gene Symbol: LOC103142753
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSPFOG00000012813
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSPFOG00000000357
Gene Symbol: AOC2
1 Cross references
404 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSPFOG00000013898
Gene Symbol: LOC103140299
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSPFOG00000002304
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSPFOG00000019378
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSPFOG00000020905
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSPFOG00000005068
Gene Symbol: AGTR2
1 Cross references
185 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSPFOG00000010655
Gene Symbol: APLNR2
1 Cross references
170 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSPFOG00000011088
Gene Symbol: APLNR2
1 Cross references
170 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSPFOG00000004178
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSPFOG00000002570
Gene Symbol: ALOX5
3 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).